The Rachel Fund for Myotonic Dystrophy
Thanks to a generous donation provided by Tribute Communities, Muscular Dystrophy Canada was able to establish the Rachel Fund for Myotonic Dystrophy in 2006.
The specific objectives of the Rachel Fund are:
- Research on therapeutics (pharmacological, cell based, genetic) and/or translational aspects that pertain directly to myotonic dystrophy
- Research on the genetic, cellular, or biochemical processes involved in myotonic dystrophy









